Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Disclosed are: a therapeutic and/or prophylactic agent for migraine, which comprises a compound having an antagonistic activity selective for an adenosine Areceptor or a pharmaceutically acceptable salt thereof as an active ingredient; a therapeutic and/or prophylactic agent for migraine, which comprises a compound having an antagonistic activity selective for an adenosine Areceptor or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the compound has an affinity for an adenosine Areceptor higher by 10 times or more than that for an adenosine Areceptor, and others.
UAA201102097A2008-07-232009-07-23Therapeutic agent for migraine
UA102106C2
(en)